Pages

▼
Wednesday, May 27, 2020

Drug Channels News Roundup, May 2020: COVID-19 and Formularies, Retail-to-Mail Trends, ABC on Biosimilars, and Social Distancing the CVS Way

›
FWIW: Summer is finally here. Before you venture outside for your lockdown barbeque, check out these noteworthy items off the Drug Channel...
Friday, May 22, 2020

Electronic Prescription Management and Enrollment for Specialty Medications—Expanding Provider Adoption of Tech-Enabled Hub Services

›
Today’s guest post comes from Kyle Grimslid, Market Development Director at CoverMyMeds. Kyle describes the complications that providers a...
Thursday, May 21, 2020

Why Do CVS And Express Scripts Rely on Secretive Private Companies to Run Their Copay Maximizer Programs?

›
In Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support , I explained a new Centers for Medica...
Tuesday, May 19, 2020

Copay Maximizers Are Displacing Accumulators—But CMS Ignores How Payers Leverage Patient Support

›
COVID-19 has not stopped the wheels of policy bureaucracy from grinding. Last week, the Centers for Medicare and Medicaid Services (CMS) rel...
Thursday, May 14, 2020

The State of Specialty Pharmacy in 2020 (video)

›
I received good feedback on Tuesday's video about retail pharmacy . So below, you'll find another brief video excerpt from my Ma...
Tuesday, May 12, 2020

The State of Retail Pharmacy 2020 (video)

›
Thanks to everyone who joined me for DCI's Industry Update and COVID-19 Impact video webinars. I enjoyed putting these events togethe...
Friday, May 08, 2020

Surprise! Brand-Name Drug Prices Fell in 2019 (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s video webinar: Industry Update and COVID-19 Impact: PBMs & Payer...
Thursday, May 07, 2020

Express Scripts vs. CVS Health: Five Lessons From the 2020 Formulary Exclusions and Some Thoughts on Patient Impact (rerun)

›
This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs &am...
Wednesday, May 06, 2020

Why Part D Plans Prefer High List Price Drugs That Raise Costs for Seniors (rerun)

›
This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs &am...
Tuesday, May 05, 2020

Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal (rerun)

›
This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs &...
Monday, May 04, 2020

Insurers + PBMs + Specialty Pharmacies + Providers: Will Vertical Consolidation Disrupt Drug Channels in 2020? (rerun)

›
This week, I’m rerunning some popular posts while I prepare for this Friday’s video webinar: Industry Update and COVID-19 Impact: PBMs &am...
Friday, May 01, 2020

Elsevier: Challenges and Trends to Watch in 2020 (Guest Post)

›
Today’s guest post comes from Trygve Anderson, Vice President of Commercial Pharmacy at Elsevier. Trygve discusses trends and challenges t...